Your search for comorbidities returned 18 results

Researchers assessed the clinical outcomes of patients with comorbid heart failure and diabetes receiving treatment with metformin and sulfonylurea.

Researchers sought to determine if peripheral artery disease is an independent risk factor for heart failure.

Researchers at AHA 2021 presented a study that sought to determine whether high leptin affects the risk for mortality or morbidity in patients with stable CHD.

Researchers aimed to determine the rate and impact of pneumonia in the PARADIGM-HF and PARAGON-HF trials.

The effects of hybrid comprehensive telerehabilitation compared with usual care were analyzed in a cohort of patients with HFrEF.

Management of patients with a recently implanted left ventricular assist device necessitates a thorough understanding of the postimplant period and of common critical care issues that may arise from the operating room to critical care discharge.

The long-term risk for a venous thromboembolism event was found to be associated with the occurrence of heart failure with preserved or reduced ejection fraction, and with left ventricular remodeling.

The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.

In patients with heart failure with preserved ejection fraction, pulmonary disease may be an independent predictor of all-cause and heart failure hospitalizations.

The researchers sought to determine whether an interatrial shunt device would improve pulmonary artery function at rest and during exercise in patients without heart failure without lessening systemic blood flow.